- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Dihydrouracil Dehydrogenase (NADP)
Total 1132 results
-
Kristina LindemannUniversity Hospital of North Norway; Haukeland University Hospital; Sorlandet... and other collaboratorsCompletedOvarian Cancer | Peritoneal CancerNorway
-
Royal Marsden NHS Foundation TrustAstraZenecaUnknownGastric Cancer | Oesophageal Cancer | Gastro-Oesophageal Junction CancerUnited Kingdom
-
Tesaro, Inc.Approved for marketingRecurrent Ovarian Cancer
-
Vejle HospitalAbbottCompletedRecurrent, Epithelial Ovarian CancerDenmark
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityAstraZenecaRecruitingProstate Cancer | Prostate Carcinoma | Metastatic Castration-resistant Prostate CancerChina
-
TakedaRecruiting
-
California Pacific Medical Center Research InstituteTesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer InstituteRecruitingMetastatic MelanomaUnited States
-
TakedaCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerJapan
-
PfizerIn Expanded Access, treating physicians are the SponsorsAvailableMetastatic Castration-Resistant Prostate Cancer
-
Asan Medical CenterNational Cancer Center, Korea; Samsung Medical Center; Seoul St. Mary's Hospital and other collaboratorsCompletedEpithelial Ovarian CancerKorea, Republic of
-
Zhongda HospitalCompleted
-
AstraZenecaCompletedHER2-ve Metastatic Breast Cancer | Germline BRCA1/2 Mutations | Somatic BRCA1/2 MutationsItaly, Spain, Poland, Taiwan, Canada, France, Germany, Korea, Republic of, Hungary, Japan, Russian Federation, Turkey, United Kingdom, United States, Bulgaria
-
Grupo Español de Investigación en Cáncer de OvarioAstraZeneca; Apices Soluciones S.L.Completed
-
Grupo Español de Investigación en Cáncer de OvarioClovis Oncology, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerSpain
-
Tesaro, Inc.Myriad Genetics, Inc.; Facing Our Risk of Cancer EmpoweredCompletedOvarian Neoplasms | Ovarian CancerUnited States, Canada
-
Samsung Medical CenterCompleted
-
Korea University Anam HospitalTakeda; Korean Cancer Study GroupNot yet recruiting
-
The University of Hong KongRecruitingEndometrial CancerHong Kong
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMetastatic Breast Cancer in Germline-PALB2 Mutations Carriers
-
Tianjin Huanhu HospitalRecruiting
-
Royal Marsden NHS Foundation TrustRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomAstraZeneca; Cancer Research UKRecruitingGynaecological CancersUnited Kingdom
-
University of UtahClovis Oncology, Inc.Terminated
-
Mario Negri Institute for Pharmacological ResearchNorth Eastern German Society of Gynaecological OncologyActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaItaly, Germany
-
Dana-Farber Cancer InstituteTesaro, Inc.Active, not recruiting
-
Matthew GalskyIcahn School of Medicine at Mount Sinai; AstraZenecaCompletedMetastatic Urothelial CancerUnited States
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
PfizerTerminated
-
UNICANCERClovis Oncology, Inc.; Fondation ARCCompletedMetastatic Breast CancerFrance
-
AstraZenecaNo longer availablePSR Ovarian Cancer With a BRCA MutationJapan
-
Trius Therapeutics LLCCompleted
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownNon Small Cell Lung CancerFrance
-
Daping Hospital and the Research Institute of Surgery...UnknownCervical Cancer | ComplicationsChina
-
Dana-Farber Cancer InstituteWithdrawnOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
GlaxoSmithKlineRecruiting
-
OnxeoRecruitingBreast Cancer | Metastatic Castration-resistant Prostate Cancer | Recurrent Epithelial Ovarian CancerUnited States
-
Yongpeng WangRecruiting
-
Centre Leon BerardGlaxoSmithKlineRecruitingMetastatic Pancreatic CancerFrance
-
Haider MahdiPfizer; Zenith EpigeneticsRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
University of ChicagoAstraZenecaRecruitingMesothelioma | Homologous Recombination DeficiencyUnited States
-
Northwell HealthTesaro, Inc.RecruitingEndometrial Cancer | Endometrial Carcinoma | Uterine Serous Carcinoma | Cancer of the Endometrium | Papillary Serous Endometrial CarcinomaUnited States
-
Massachusetts General HospitalPfizerRecruiting
-
North Eastern German Society of Gynaecological...Clovis Oncology, Inc.; Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus...Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Clear Cell CarcinomaGermany
-
Shadia Jalal, MDGlaxoSmithKline; Indiana University School of MedicineActive, not recruitingAdenocarcinoma | Gastric Cancer | Esophageal CancerUnited States
-
PfizerCompletedBreast Neoplasms | Metastatic Breast CancerUnited States
-
AstraZenecaActive, not recruitingSolid TumorsBelgium, United Kingdom, Switzerland, Australia
-
PfizerActive, not recruitingNeoplasms | Breast NeoplasmsJapan
-
Ospedale Policlinico San MartinoCRO "Centro Clinical Trials" IRCCS Ospedale Policlinico San Martino; Laboratory...Withdrawn
-
GlaxoSmithKlineActive, not recruitingNeoplasms, BreastUnited States, Argentina, France, Netherlands, Finland, Spain, Israel, Poland, Romania, Mexico, Canada, Belgium, Germany, Hungary, Portugal, United Kingdom, Ireland, Australia, Italy, Brazil, Japan, Austria, Russian Federation, South... and more
-
AstraZenecaBritish Columbia Cancer AgencyCompleted